Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Qilu Pharmaceutical
Pharma
AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia
AZ pledged a $15 billion China investment. BI and Simcere inked a potential $1 billion IBD deal. Daiichi is navigating a complex ADC market. And more.
Angus Liu
Jan 30, 2026 7:45am
RemeGen, Roche, Hengrui and more—Fierce Pharma Asia
May 16, 2025 10:20am
FDA allows more imports of key cancer med from China's Qilu
Jul 12, 2023 12:52pm
Leqembi, Enhertu, Samsung Biologics—Fierce Pharma Asia
Jun 9, 2023 9:35am
Sanofi, AZ, Lilly and more win in China's expanded purchase bid
Sep 25, 2019 11:02am
U.S. generics players, Chi-Med and more—FiercePharmaAsia
Apr 19, 2019 9:43am
